Injectable and topical neurotoxins in dermatology
Botulinum toxin is a potentially deadly anaerobic bacterial toxin that acts by inhibiting release of acetylcholine at the neuromuscular junction, thereby inhibiting contraction of the exposed striated muscle. There are currently 4 botulinum toxin preparations approved by the US Food and Drug Administration (FDA): onabotulinumtoxin, abobotulinumtoxin, incobotulinumtoxin and rimabotulinumtoxin. While significant overlap exists, each product has unique properties and specifications, including dosing, diffusion, and storage.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Cerrene N. Giordano, Seth L. Matarasso, David M. Ozog Tags: Continuing medical education Source Type: research
More News: Academies | Brain | Continuing Medical Education | Dermatology | Education | Food and Drug Administration (FDA) | Neurology | Skin | Universities & Medical Training